University of Virginia at AES 2026

Dec 4–8, 2026 Denver, CO ~6.2k attendees Website

University of Virginia brings 10 presentations to AES 2026 in Denver. Its program covers self-sustaining status epilepticus, metabolic targets for new seizure treatments such as beta-hydroxybutyrate, vascular risk in epilepsy, daily functioning in older adults and the national plan for epilepsy, plus an introduction to a federal clinical trials methodology course.

OrganizationAES 2026 Attendance
University of Virginia
Charlottesville, VA
Universities and research institutes
Workshop
Fri, Dec 4
3:00pm–3:30pm
Introduction to the NINDS Clinical Trials Methodology Course
How a National Institute of Neurological Disorders and Stroke course trains early-career investigators to design clinical trials, and how to apply.
Clinical trials
Workshop
Fri, Dec 4
3:00pm–3:30pm
Professional Development | Introduction to the NINDS Clinical Trials Methodology Course
How a National Institute of Neurological Disorders and Stroke course trains early-career investigators to design clinical trials, and how to apply.
Clinical trials
Workshop
Sat, Dec 5
7:30am–5:00pm
Workshop
Sun, Dec 6
10:30am–12:00pm

Explore the full AES 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Denver. Leave your work email and we’ll be in touch.

Privacy

Download the full AES 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Virginia

Tell us what you sell and we’ll find the people at University of Virginia most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and online program, and each exhibitor’s own profile and website. Submit a correction